BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26936084)

  • 1. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
    Habara A; Steinberg MH
    Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting clinical severity in sickle cell anaemia.
    Steinberg MH
    Br J Haematol; 2005 May; 129(4):465-81. PubMed ID: 15877729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab.
    Patel DK; Purohit P; Dehury S; Das P; Dutta A; Meher S; Patel S; Bag S; Mashon RS; Das K
    Int J Lab Hematol; 2014 Aug; 36(4):444-50. PubMed ID: 24245819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic etiologies for phenotypic diversity in sickle cell anemia.
    Steinberg MH
    ScientificWorldJournal; 2009 Jan; 9():46-67. PubMed ID: 19151898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modifiers of sickle cell disease.
    Steinberg MH; Sebastiani P
    Am J Hematol; 2012 Aug; 87(8):795-803. PubMed ID: 22641398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical pathophysiology of sickle cell disease.
    Embury SH
    Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.
    Quinn CT
    Exp Biol Med (Maywood); 2016 Apr; 241(7):679-88. PubMed ID: 27013545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifier genes and sickle cell anemia.
    Steinberg MH; Adewoye AH
    Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
    Nagel RL; Steinberg MH
    Pediatr Pathol Mol Med; 2001; 20(2):123-36. PubMed ID: 12673837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
    Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
    JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the phenotypic diversity of sickle cell anemia.
    Steinberg MH
    Hemoglobin; 1996 Feb; 20(1):1-19. PubMed ID: 8745428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease: a multigenic perspective of a single gene disorder.
    Kutlar A
    Hemoglobin; 2007; 31(2):209-24. PubMed ID: 17486504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association studies in β-hemoglobinopathies.
    Thein SL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():354-61. PubMed ID: 24319204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic studies of fetal hemoglobin in the Arab-Indian haplotype sickle cell-β(0) thalassemia.
    Alsultan A; Ngo D; Bae H; Sebastiani P; Baldwin CT; Melista E; Suliman AM; Albuali WH; Nasserullah Z; Luo HY; Chui DH; Steinberg MH; Al-Ali AK
    Am J Hematol; 2013 Jun; 88(6):531-2. PubMed ID: 23483609
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Modifiers of Sickle Cell Disease.
    Pincez T; Ashley-Koch AE; Lettre G; Telen MJ
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1097-1124. PubMed ID: 36400533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
    Fertrin KY; Costa FF
    Expert Rev Hematol; 2010 Aug; 3(4):443-58. PubMed ID: 21083035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic modifiers of homozygous sickle cell disease].
    Hartmann K; Kulozik AE
    Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.